Sign in

CIK 0001855175 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Contineum Therapeutics, Inc.

Sign in to watch
Ticker
CTNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
271467257
Phone
(858) 333-5280
Business address
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
  1. 3 Insider Initial Statement of Ownership
  2. 8-K Event Other events
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Executive or director change
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. 10-K Report Annual Report
  8. 8-K Event Results of operations
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Planned sale Chief Scientific Officer sold 1,010 shares at $16.02 ($16,177)
  17. 4 Planned sale Chief Scientific Officer sold 6,190 shares at an average $16.38 ($101,421)
  18. 144 Insider Sale of Securities
  19. SC 13G Stake Amended Statement of Ownership
  20. 10-Q Report Quarterly Report

Page 7 of 11 · 202 filings